Industry: Pharma & Healthcare
Published Date: 2026-01-08
Pages: 124 Pages
Report ld: 5587520
Request Sample
Customized Report
Dry Powder Inhalation Excipients Market Size(US$)

CAGR 2026-2032
5.4%
Market Size,2032
USD 2,613
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Dry Powder Inhalation Excipients market was valued at US$ 1817 million in 2025 and is anticipated to reach US$ 2613 million by 2032, at a CAGR of 5.4% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Dry Powder Inhalation Excipients competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Dry powder inhalation excipients are auxiliary components used in dry powder inhalation formulations to improve drug dispersion, stability, and inhalation performance. They typically include lactose, mannitol, and other sugars, as well as certain inorganic salts. By optimizing the particle size and distribution of the drug, these excipients enhance the lung deposition rate and bioavailability of the drug. Dry powder inhalation excipients play a crucial role in the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease, ensuring effective drug inhalation and therapeutic effects.
The North American market for Dry Powder Inhalation Excipients is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Dry Powder Inhalation Excipients is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Dry Powder Inhalation Excipients include Protheragen-ING, DFE Pharma, Meggle-Pharma, Pfanstiehl, Merck, Sheffield (Kerry), Armor Pharma, Abbott, Norvatis, Bayer, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Dry Powder Inhalation Excipients market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Dry Powder Inhalation Excipients. The Dry Powder Inhalation Excipients market size, estimates, and forecasts are provided in terms of sales volume (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Dry Powder Inhalation Excipients market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Dry Powder Inhalation Excipients manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Dry Powder Inhalation Excipients manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Dry Powder Inhalation Excipients sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Dry Powder Inhalation Excipients Market Overview
1.1 Product Definition
1.2 Dry Powder Inhalation Excipients by Type
1.2.1 Global Dry Powder Inhalation Excipients Market Value by Type: 2025 vs 2032
1.2.2 Lactose
1.2.3 Magnesium Stearate
1.2.4 Others
1.3 Dry Powder Inhalation Excipients by Application
1.3.1 Global Dry Powder Inhalation Excipients Market Value by Application: 2025 vs 2032
1.3.2 DPI
1.3.3 MDI
1.3.4 Nebulizer
1.3.5 Others
1.4 Global Dry Powder Inhalation Excipients Market Size Estimates and Forecasts
1.4.1 Global Dry Powder Inhalation Excipients Revenue 2021–2032
1.4.2 Global Dry Powder Inhalation Excipients Sales 2021–2032
1.4.3 Global Dry Powder Inhalation Excipients Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Dry Powder Inhalation Excipients Market Competition by Manufacturers
2.1 Global Dry Powder Inhalation Excipients Sales Market Share by Manufacturers (2021–2026)
2.2 Global Dry Powder Inhalation Excipients Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Dry Powder Inhalation Excipients Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Dry Powder Inhalation Excipients, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Dry Powder Inhalation Excipients, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Dry Powder Inhalation Excipients, Product Types and Applications
2.7 Global Key Manufacturers of Dry Powder Inhalation Excipients, Date of Entry into the Industry
2.8 Global Dry Powder Inhalation Excipients Market Competitive Situation and Trends
2.8.1 Global Dry Powder Inhalation Excipients Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Dry Powder Inhalation Excipients Players Market Share by Revenue
2.8.3 Global Dry Powder Inhalation Excipients Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dry Powder Inhalation Excipients Market Scenario by Region
3.1 Global Dry Powder Inhalation Excipients Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Dry Powder Inhalation Excipients Sales by Region: 2021–2032
3.2.1 Global Dry Powder Inhalation Excipients Sales by Region: 2021–2026
3.2.2 Global Dry Powder Inhalation Excipients Sales by Region: 2027–2032
3.3 Global Dry Powder Inhalation Excipients Revenue by Region: 2021–2032
3.3.1 Global Dry Powder Inhalation Excipients Revenue by Region: 2021–2026
3.3.2 Global Dry Powder Inhalation Excipients Revenue by Region: 2027–2032
3.4 North America Dry Powder Inhalation Excipients Market Facts & Figures by Country
3.4.1 North America Dry Powder Inhalation Excipients Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Dry Powder Inhalation Excipients Sales by Country (2021–2032)
3.4.3 North America Dry Powder Inhalation Excipients Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dry Powder Inhalation Excipients Market Facts & Figures by Country
3.5.1 Europe Dry Powder Inhalation Excipients Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Dry Powder Inhalation Excipients Sales by Country (2021–2032)
3.5.3 Europe Dry Powder Inhalation Excipients Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dry Powder Inhalation Excipients Market Facts & Figures by Region
3.6.1 Asia Pacific Dry Powder Inhalation Excipients Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Dry Powder Inhalation Excipients Sales by Region (2021–2032)
3.6.3 Asia Pacific Dry Powder Inhalation Excipients Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Dry Powder Inhalation Excipients Market Facts & Figures by Country
3.7.1 Latin America Dry Powder Inhalation Excipients Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Dry Powder Inhalation Excipients Sales by Country (2021–2032)
3.7.3 Latin America Dry Powder Inhalation Excipients Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Dry Powder Inhalation Excipients Market Facts & Figures by Country
3.8.1 Middle East and Africa Dry Powder Inhalation Excipients Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Dry Powder Inhalation Excipients Sales by Country (2021–2032)
3.8.3 Middle East and Africa Dry Powder Inhalation Excipients Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dry Powder Inhalation Excipients Sales by Type (2021–2032)
4.1.1 Global Dry Powder Inhalation Excipients Sales by Type (2021–2026)
4.1.2 Global Dry Powder Inhalation Excipients Sales by Type (2027–2032)
4.1.3 Global Dry Powder Inhalation Excipients Sales Market Share by Type (2021–2032)
4.2 Global Dry Powder Inhalation Excipients Revenue by Type (2021–2032)
4.2.1 Global Dry Powder Inhalation Excipients Revenue by Type (2021–2026)
4.2.2 Global Dry Powder Inhalation Excipients Revenue by Type (2027–2032)
4.2.3 Global Dry Powder Inhalation Excipients Revenue Market Share by Type (2021–2032)
4.3 Global Dry Powder Inhalation Excipients Price by Type (2021–2032)
5 Segment by Application
5.1 Global Dry Powder Inhalation Excipients Sales by Application (2021–2032)
5.1.1 Global Dry Powder Inhalation Excipients Sales by Application (2021–2026)
5.1.2 Global Dry Powder Inhalation Excipients Sales by Application (2027–2032)
5.1.3 Global Dry Powder Inhalation Excipients Sales Market Share by Application (2021–2032)
5.2 Global Dry Powder Inhalation Excipients Revenue by Application (2021–2032)
5.2.1 Global Dry Powder Inhalation Excipients Revenue by Application (2021–2026)
5.2.2 Global Dry Powder Inhalation Excipients Revenue by Application (2027–2032)
5.2.3 Global Dry Powder Inhalation Excipients Revenue Market Share by Application (2021–2032)
5.3 Global Dry Powder Inhalation Excipients Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Protheragen-ING
6.1.1 Protheragen-ING Company Information
6.1.2 Protheragen-ING Description and Business Overview
6.1.3 Protheragen-ING Dry Powder Inhalation Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Protheragen-ING Dry Powder Inhalation Excipients Product Portfolio
6.1.5 Protheragen-ING Recent Developments/Updates
6.2 DFE Pharma
6.2.1 DFE Pharma Company Information
6.2.2 DFE Pharma Description and Business Overview
6.2.3 DFE Pharma Dry Powder Inhalation Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 DFE Pharma Dry Powder Inhalation Excipients Product Portfolio
6.2.5 DFE Pharma Recent Developments/Updates
6.3 Meggle-Pharma
6.3.1 Meggle-Pharma Company Information
6.3.2 Meggle-Pharma Description and Business Overview
6.3.3 Meggle-Pharma Dry Powder Inhalation Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Meggle-Pharma Dry Powder Inhalation Excipients Product Portfolio
6.3.5 Meggle-Pharma Recent Developments/Updates
6.4 Pfanstiehl
6.4.1 Pfanstiehl Company Information
6.4.2 Pfanstiehl Description and Business Overview
6.4.3 Pfanstiehl Dry Powder Inhalation Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Pfanstiehl Dry Powder Inhalation Excipients Product Portfolio
6.4.5 Pfanstiehl Recent Developments/Updates
6.5 Merck
6.5.1 Merck Company Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Dry Powder Inhalation Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Merck Dry Powder Inhalation Excipients Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Sheffield (Kerry)
6.6.1 Sheffield (Kerry) Company Information
6.6.2 Sheffield (Kerry) Description and Business Overview
6.6.3 Sheffield (Kerry) Dry Powder Inhalation Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Sheffield (Kerry) Dry Powder Inhalation Excipients Product Portfolio
6.6.5 Sheffield (Kerry) Recent Developments/Updates
6.7 Armor Pharma
6.7.1 Armor Pharma Company Information
6.7.2 Armor Pharma Description and Business Overview
6.7.3 Armor Pharma Dry Powder Inhalation Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Armor Pharma Dry Powder Inhalation Excipients Product Portfolio
6.7.5 Armor Pharma Recent Developments/Updates
6.8 Abbott
6.8.1 Abbott Company Information
6.8.2 Abbott Description and Business Overview
6.8.3 Abbott Dry Powder Inhalation Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Abbott Dry Powder Inhalation Excipients Product Portfolio
6.8.5 Abbott Recent Developments/Updates
6.9 Norvatis
6.9.1 Norvatis Company Information
6.9.2 Norvatis Description and Business Overview
6.9.3 Norvatis Dry Powder Inhalation Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Norvatis Dry Powder Inhalation Excipients Product Portfolio
6.9.5 Norvatis Recent Developments/Updates
6.10 Bayer
6.10.1 Bayer Company Information
6.10.2 Bayer Description and Business Overview
6.10.3 Bayer Dry Powder Inhalation Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Bayer Dry Powder Inhalation Excipients Product Portfolio
6.10.5 Bayer Recent Developments/Updates
6.11 Jiangsu Daoning Drug
6.11.1 Jiangsu Daoning Drug Company Information
6.11.2 Jiangsu Daoning Drug Description and Business Overview
6.11.3 Jiangsu Daoning Drug Dry Powder Inhalation Excipients Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Jiangsu Daoning Drug Dry Powder Inhalation Excipients Product Portfolio
6.11.5 Jiangsu Daoning Drug Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dry Powder Inhalation Excipients Industry Chain Analysis
7.2 Dry Powder Inhalation Excipients Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dry Powder Inhalation Excipients Production Mode & Process Analysis
7.4 Dry Powder Inhalation Excipients Sales and Marketing
7.4.1 Dry Powder Inhalation Excipients Sales Channels
7.4.2 Dry Powder Inhalation Excipients Distributors
7.5 Dry Powder Inhalation Excipients Customer Analysis
8 Dry Powder Inhalation Excipients Market Dynamics
8.1 Dry Powder Inhalation Excipients Industry Trends
8.2 Dry Powder Inhalation Excipients Market Drivers
8.3 Dry Powder Inhalation Excipients Market Challenges
8.4 Dry Powder Inhalation Excipients Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Dry Powder Inhalation Excipients market is projected to grow from US$ 1817 million in 2025 to US$ 2613 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 159
USD 4900.00
(Single User License)
The global Dry Powder Inhalation Excipients market size was US$ 1817 million in 2025 and is forecast to reach a readjusted size of US$ 2613 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 99
USD 4250.00
(Single User License)
The global market for Dry Powder Inhalation Excipients was estimated to be worth US$ 1817 million in 2025 and is projected to reach US$ 2613 million, growing at a CAGR of 5.4% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 123
USD 3950.00
(Single User License)
The global Dry Powder Inhalation Excipients market is projected to grow from US$ 1733 million in 2024 to US$ 2491 million by 2031, at a CAGR of 5.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 159
USD 4900.00
(Single User License)
The global Dry Powder Inhalation Excipients market size was US$ 1733 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 92
USD 4250.00
(Single User License)
The global market for Dry Powder Inhalation Excipients was estimated to be worth US$ 1733 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 127
USD 3950.00
(Single User License)
The global market for Dry Powder Inhalation Excipients was valued at US$ 1733 million in the year 2024 and is projected to reach a revised size of US$ 2491 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Published Date: 2025-03-13
Pages: 97
USD 2900.00
(Single User License)
The global Dry Powder Inhalation Excipients revenue was US$ 1674 million in 2023 and is forecast to a readjusted size of US$ 2376 million by 2030 with a CAGR of 5.4% during the review period (2024-2030).
Published Date: 2025-01-01
Pages: 133
USD 4350.00
(Single User License)
The global market for Dry Powder Inhalation Excipients was valued at US$ 1674 million in the year 2023 and is projected to reach a revised size of US$ 2376 million by 2030, growing at a CAGR of 5.4% during the forecast period.
Published Date: 2025-01-01
Pages: 91
USD 2900.00
(Single User License)
The global market for Dry Powder Inhalation Excipients was estimated to be worth US$ 1674 million in 2023 and is forecast to a readjusted size of US$ 2376 million by 2030 with a CAGR of 5.4% during the forecast period 2024-2030.
Published Date: 2025-01-01
Pages: 117
USD 3950.00
(Single User License)
The global Dry Powder Inhalation Excipients market is projected to grow from US$ 1817 million in 2025 to US$ 2613 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 159
The global Dry Powder Inhalation Excipients market size was US$ 1817 million in 2025 and is forecast to reach a readjusted size of US$ 2613 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 99
The global market for Dry Powder Inhalation Excipients was estimated to be worth US$ 1817 million in 2025 and is projected to reach US$ 2613 million, growing at a CAGR of 5.4% from 2026 to 2032.
Published: 2026-01-19
Pages: 123
The global Dry Powder Inhalation Excipients market is projected to grow from US$ 1733 million in 2024 to US$ 2491 million by 2031, at a CAGR of 5.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 159
The global Dry Powder Inhalation Excipients market size was US$ 1733 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 92
The global market for Dry Powder Inhalation Excipients was estimated to be worth US$ 1733 million in 2024 and is forecast to a readjusted size of US$ 2491 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 127
The global market for Dry Powder Inhalation Excipients was valued at US$ 1733 million in the year 2024 and is projected to reach a revised size of US$ 2491 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Published: 2025-03-13
Pages: 97
The global Dry Powder Inhalation Excipients revenue was US$ 1674 million in 2023 and is forecast to a readjusted size of US$ 2376 million by 2030 with a CAGR of 5.4% during the review period (2024-2030).
Published: 2025-01-01
Pages: 133
The global market for Dry Powder Inhalation Excipients was valued at US$ 1674 million in the year 2023 and is projected to reach a revised size of US$ 2376 million by 2030, growing at a CAGR of 5.4% during the forecast period.
Published: 2025-01-01
Pages: 91
The global market for Dry Powder Inhalation Excipients was estimated to be worth US$ 1674 million in 2023 and is forecast to a readjusted size of US$ 2376 million by 2030 with a CAGR of 5.4% during the forecast period 2024-2030.
Published: 2025-01-01
Pages: 117
REPORT COVERAGE
DESCRIPTION
MARKET SEGMENTATION
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now